Tapewire

Nasdaq · USD

CDNA

CareDx, Inc.

Export transactions ↓
Tapewire entity
4344
SEC CIK
0001217234
Parsed reports
707

Last 12 months

Inside the activity.

0 purchase rows · 26 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202502
Jan 202603
Feb 202601
Mar 202600
Apr 202601
May 202603
Jun 202606
Jul 202604
Aug 202605
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 06, 2025 Filed Oct 7, 2025 22:55 UTC GrantCommon Stock 1,753 $0.00 $0.00
Disclosure

SEC source: 0001366412-25-000010 · form4-10072025_101035.xml · nonDerivative · entry 1

Goldberg Michael · CIK 0001366412 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,969

F1 · shares: Represents an automatic quarterly grant of common stock to the Reporting Person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
September 12, 2025 Filed Sep 15, 2025 20:03 UTC
Meng JessicaChief Commercial Officer
Tax withholdingCommon Stock 4,703 $13.53 $63,631.59
Disclosure

SEC source: 0002036499-25-000006 · form4-09152025_080909.xml · nonDerivative · entry 1

Meng Jessica · CIK 0002036499 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,629

F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document
September 12, 2025 Filed Sep 15, 2025 20:01 UTC
Kennedy KeithChief Operating Officer
Tax withholdingCommon Stock 7,987 $13.53 $108,064.11
Disclosure

SEC source: 0001543503-25-000006 · form4-09152025_080953.xml · nonDerivative · entry 1

Kennedy Keith · CIK 0001543503 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,309

F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document
September 11, 2025 Filed Sep 12, 2025 21:09 UTC Exercise / conversionStock Option (right to buy) · Derivative 29,136 $0.00 Strike: $7.96 $0.00
Disclosure

SEC source: 0001415889-25-024408 · form4-09122025_090941.xml · derivative · entry 2

Bickerstaff George · CIK 0001329646 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 29,136 shares

Expires 2033-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on June 16, 2024.

Read SEC document
September 11, 2025 Filed Sep 12, 2025 21:09 UTC Exercise / conversionCommon Stock 29,136 $7.96 $231,922.56
Disclosure

SEC source: 0001415889-25-024408 · form4-09122025_090941.xml · nonDerivative · entry 1

Bickerstaff George · CIK 0001329646 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,266

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 07, 2025 Filed Aug 11, 2025 20:35 UTC
SMITH NATHANChief Financial Officer
GrantCommon Stock 42,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-021431 · form4-08112025_080811.xml · nonDerivative · entry 1

SMITH NATHAN · CIK 0002079385 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,000

F1 · shares: The reported securities are represented by restricted stock units ("RSUs"). Pursuant to the terms of the RSU, 25% of the total number of shares underlying the RSU shall vest on August 7, 2026, and 1/16th of the total number of shares underlying the RSU shall vest in quarterly installments thereafter until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.

F2 · price: Each RSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
August 05, 2025 Filed Aug 7, 2025 20:00 UTC
Novack Jeffrey AdamSecretary and General Counsel
SaleCommon Stock 2,688 $12.79 $34,380.60
Disclosure

SEC source: 0001415889-25-021242 · form4-08072025_080827.xml · nonDerivative · entry 1

Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,930

F1 · kind: The transaction reported in this row was effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 19, 2024.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.33 to $13.03 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 01, 2025 Filed Aug 5, 2025 20:29 UTC
Novack Jeffrey AdamSecretary and General Counsel
Tax withholdingCommon Stock 2,873 $12.22 $35,108.06
Disclosure

SEC source: 0001415889-25-021035 · form4-08052025_080832.xml · nonDerivative · entry 1

Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,618

F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document
August 01, 2025 Filed Aug 5, 2025 20:25 UTC
Jain AbhishekChief Financial Officer
Tax withholdingCommon Stock 7,687 $12.22 $93,935.14
Disclosure

SEC source: 0001415889-25-021031 · form4-08052025_080810.xml · nonDerivative · entry 1

Jain Abhishek · CIK 0001931277 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 319,725

F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document
July 08, 2025 Filed Jul 8, 2025 22:39 UTC GrantCommon Stock 1,218 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-019546 · form4-07082025_100746.xml · nonDerivative · entry 1

Goldberg Michael · CIK 0001366412 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,216

F1 · shares: Represents an automatic quarterly grant of common stock to the Reporting Person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
July 07, 2025 Filed Jul 10, 2025 20:04 UTC
Maag PeterDirector
SaleCommon Stock 10,000 $18.58 $185,831.00
Disclosure

SEC source: 0001415889-25-019632 · form4-07102025_080700.xml · nonDerivative · entry 1

Maag Peter · CIK 0001613855 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 308,846

F1 · shares: The transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 21, 2024.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.40 to $18.86 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 07, 2025 Filed Jul 14, 2025 20:01 UTC
Novack Jeffrey AdamSecretary and General Counsel
Tax withholdingCommon Stock 276 $18.45 $5,092.20
Disclosure

SEC source: 0001415889-25-019703 · form4-07142025_080723.xml · nonDerivative · entry 1

Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,491

F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document
June 18, 2025 Filed Jun 23, 2025 20:30 UTC SaleCommon Stock 10,570 $19.16 $202,565.59
Disclosure

SEC source: 0000950170-25-089022 · ownership.xml · nonDerivative · entry 1

Valantine Hannah · CIK 0001855608 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,994

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on December 12, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00 to $19.62, inclusive. The reporting person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4

Read SEC document
June 17, 2025 Filed Jun 20, 2025 20:30 UTC
Maag PeterDirector
SaleCommon Stock 10,000 $19.24 $192,420.00
Disclosure

SEC source: 0000950170-25-088541 · ownership.xml · nonDerivative · entry 1

Maag Peter · CIK 0001613855 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 318,846

F1 · shares: The transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 21, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.80 to $19.52, inclusive. The reporting person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 20:30 UTC GrantCommon Stock 12,103 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-087411 · ownership.xml · nonDerivative · entry 1

COURNOYER CHRISTINE · CIK 0001180466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,148

F1 · shares: The reported securities are represented by restricted stock units which shall vest in one installment on the earlier of (i) June 13, 2026 or (ii) the day immediately prior to the first annual meeting of stockholders held by CareDx, Inc. after June 13, 2025.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 20:30 UTC GrantCommon Stock 12,103 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-087412 · ownership.xml · nonDerivative · entry 1

Valantine Hannah · CIK 0001855608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,564

F1 · shares: The reported securities are represented by restricted stock units which shall vest in one installment on earlier of (i) June 13, 2026 or (ii) the day immediately prior to the first annual meeting of stockholders held by CareDx, Inc. after June 13, 2025.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 20:56 UTC GrantCommon Stock 12,103 $0.00 $0.00
Disclosure

SEC source: 0001366412-25-000007 · wk-form4_1750193759.xml · nonDerivative · entry 1

Goldberg Michael · CIK 0001366412 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,998

F1 · shares: The reported securities are represented by restricted stock units which shall vest in one installment on earlier of (i) June 13, 2026 or (ii) the day immediately prior to the first annual meeting of stockholders held by CareDx, Inc. after June 13, 2025.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 20:35 UTC
Cohen Fred EDirector
GrantCommon Stock 12,103 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-087424 · ownership.xml · nonDerivative · entry 1

Cohen Fred E · CIK 0001339358 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,265

F1 · shares: The reported securities are represented by restricted stock units which shall vest in one installment on the earlier of (i) June 13, 2026 or (ii) the day immediately prior to the first annual meeting of stockholders held by CareDx, Inc. after June 13, 2025.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 20:30 UTC GrantCommon Stock 12,103 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-087415 · ownership.xml · nonDerivative · entry 1

Riggsbee Richard Bryan · CIK 0001621899 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,517

F1 · shares: The reported securities are represented by restricted stock units which shall vest in one installment on the earlier of (i) June 13, 2026 or (ii) the day immediately prior to the first annual meeting of stockholders held by CareDx, Inc. after June 13, 2025.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 20:31 UTC
Maag PeterDirector
GrantCommon Stock 12,103 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-087417 · ownership.xml · nonDerivative · entry 1

Maag Peter · CIK 0001613855 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 328,846

F1 · shares: The reported securities are represented by restricted stock units which shall vest in one installment on the earlier of (i) June 13, 2026 or (ii) the day immediately prior to the first annual meeting of stockholders held by CareDx, Inc. after June 13, 2025.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 20:30 UTC GrantCommon Stock 12,103 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-087409 · ownership.xml · nonDerivative · entry 1

TORRES ARTHUR A · CIK 0001251737 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,235

F1 · shares: The reported securities are represented by restricted stock units which shall vest in one installment on the earlier of (i) June 13, 2026 or (ii) the day immediately prior to the first annual meeting of stockholders held by CareDx, Inc. after June 13, 2025.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 20:30 UTC GrantCommon Stock 12,103 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-087413 · ownership.xml · nonDerivative · entry 1

Bickerstaff George · CIK 0001329646 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,130

F1 · shares: The reported securities are represented by restricted stock units which shall vest in one installment on the earlier of (i) June 13, 2026 or (ii) the day immediately prior to the first annual meeting of stockholders held by CareDx, Inc. after June 13, 2025.

Read SEC document
June 11, 2025 Filed Jun 13, 2025 17:06 UTC Exercise / conversionStock Option (right to buy) · Derivative 4,391 $0.00 Strike: $7.96 $0.00
Disclosure

SEC source: 0000950170-25-086355 · ownership.xml · derivative · entry 5

HAGSTROM WILLIAM A · CIK 0001042875 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,391 shares

Expires 2033-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to this option vested fully on June 16, 2024.

Read SEC document
June 11, 2025 Filed Jun 13, 2025 17:06 UTC Exercise / conversionStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $14.74 $0.00
Disclosure

SEC source: 0000950170-25-086355 · ownership.xml · derivative · entry 4

HAGSTROM WILLIAM A · CIK 0001042875 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2028-06-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares subject to this option vested fully on June 20, 2019.

Read SEC document
June 11, 2025 Filed Jun 13, 2025 17:06 UTC SaleCommon Stock 19,391 $19.90 $385,917.74
Disclosure

SEC source: 0000950170-25-086355 · ownership.xml · nonDerivative · entry 3

HAGSTROM WILLIAM A · CIK 0001042875 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,979

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.69 to $20.20, inclusive. The reporting person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
June 11, 2025 Filed Jun 13, 2025 17:06 UTC Exercise / conversionCommon Stock 4,391 $7.96 $34,952.36
Disclosure

SEC source: 0000950170-25-086355 · ownership.xml · nonDerivative · entry 2

HAGSTROM WILLIAM A · CIK 0001042875 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,370

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 11, 2025 Filed Jun 13, 2025 17:06 UTC Exercise / conversionCommon Stock 15,000 $14.74 $221,100.00
Disclosure

SEC source: 0000950170-25-086355 · ownership.xml · nonDerivative · entry 1

HAGSTROM WILLIAM A · CIK 0001042875 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,979

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 06, 2025 Filed Jun 10, 2025 20:30 UTC
Novack Jeffrey AdamSecretary and General Counsel
Tax withholdingCommon Stock 2,583 $19.52 $50,420.16
Disclosure

SEC source: 0000950170-25-084373 · ownership.xml · nonDerivative · entry 1

Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,767

F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document
May 28, 2025 Filed May 30, 2025 17:57 UTC Exercise / conversionStock Option (right to buy) · Derivative 510 $0.00 Strike: $5.85 $0.00
Disclosure

SEC source: 0000950170-25-079892 · ownership.xml · derivative · entry 7

HAGSTROM WILLIAM A · CIK 0001042875 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 510 shares

Expires 2025-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to this option vested fully on June 17, 2016.

Read SEC document
May 28, 2025 Filed May 30, 2025 17:57 UTC Exercise / conversionStock Option (right to buy) · Derivative 24,745 $0.00 Strike: $7.96 $0.00
Disclosure

SEC source: 0000950170-25-079892 · ownership.xml · derivative · entry 6

HAGSTROM WILLIAM A · CIK 0001042875 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,391

Underlying: Common Stock · 24,745 shares

Expires 2033-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to this option vested fully on June 16, 2024.

Read SEC document
May 28, 2025 Filed May 30, 2025 17:57 UTC Exercise / conversionStock Option (right to buy) · Derivative 4,745 $0.00 Strike: $4.95 $0.00
Disclosure

SEC source: 0000950170-25-079892 · ownership.xml · derivative · entry 5

HAGSTROM WILLIAM A · CIK 0001042875 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,745 shares

Expires 2026-07-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares subject to this option vested fully on July 1, 2017.

Read SEC document
May 28, 2025 Filed May 30, 2025 17:57 UTC SaleCommon Stock 30,000 $17.45 $523,413.00
Disclosure

SEC source: 0000950170-25-079892 · ownership.xml · nonDerivative · entry 4

HAGSTROM WILLIAM A · CIK 0001042875 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,979

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.35 to $17.57, inclusive. The reporting person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
May 28, 2025 Filed May 30, 2025 17:57 UTC Exercise / conversionCommon Stock 510 $5.85 $2,983.50
Disclosure

SEC source: 0000950170-25-079892 · ownership.xml · nonDerivative · entry 3

HAGSTROM WILLIAM A · CIK 0001042875 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,979

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 28, 2025 Filed May 30, 2025 17:57 UTC Exercise / conversionCommon Stock 24,745 $7.96 $196,970.20
Disclosure

SEC source: 0000950170-25-079892 · ownership.xml · nonDerivative · entry 2

HAGSTROM WILLIAM A · CIK 0001042875 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,469

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 28, 2025 Filed May 30, 2025 17:57 UTC Exercise / conversionCommon Stock 4,745 $4.95 $23,487.75
Disclosure

SEC source: 0000950170-25-079892 · ownership.xml · nonDerivative · entry 1

HAGSTROM WILLIAM A · CIK 0001042875 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,724

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 27, 2025 Filed May 29, 2025 20:36 UTC
Jain AbhishekChief Financial Officer
Tax withholdingCommon Stock 1,982 $17.63 $34,942.66
Disclosure

SEC source: 0000950170-25-079036 · ownership.xml · nonDerivative · entry 1

Jain Abhishek · CIK 0001931277 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 327,412

F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document
May 12, 2025 Filed May 14, 2025 21:18 UTC Exercise / conversionStock Option (right to buy) · Derivative 29,136 $0.00 Strike: $7.96 $0.00
Disclosure

SEC source: 0001180466-25-000005 · wk-form4_1747257527.xml · derivative · entry 3

COURNOYER CHRISTINE · CIK 0001180466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 29,136 shares

Expires 2033-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares subject to this option vested fully on June 16, 2024.

Read SEC document
May 12, 2025 Filed May 14, 2025 21:18 UTC SaleCommon Stock 29,136 $15.96 $465,022.21
Disclosure

SEC source: 0001180466-25-000005 · wk-form4_1747257527.xml · nonDerivative · entry 2

COURNOYER CHRISTINE · CIK 0001180466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,045

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.95 to $15.98, inclusive. The reporting person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
May 12, 2025 Filed May 14, 2025 21:18 UTC Exercise / conversionCommon Stock 29,136 $7.96 $231,922.56
Disclosure

SEC source: 0001180466-25-000005 · wk-form4_1747257527.xml · nonDerivative · entry 1

COURNOYER CHRISTINE · CIK 0001180466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,181

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 06, 2025 Filed May 8, 2025 20:31 UTC SaleCommon Stock 16,700 $14.13 $235,929.25
Disclosure

SEC source: 0001180466-25-000003 · wk-form4_1746736268.xml · nonDerivative · entry 1

COURNOYER CHRISTINE · CIK 0001180466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,045

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.0900 to $14.1750, inclusive. The reporting person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
May 05, 2025 Filed May 7, 2025 20:38 UTC
Novack Jeffrey AdamSecretary and General Counsel
SaleCommon Stock 2,688 $14.70 $39,513.60
Disclosure

SEC source: 0000950170-25-065797 · ownership.xml · nonDerivative · entry 1

Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 121,350

F1 · kind: The transaction reported in this row was effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 19, 2024.

Read SEC document
May 01, 2025 Filed May 5, 2025 20:53 UTC
Novack Jeffrey AdamSecretary and General Counsel
Tax withholdingCommon Stock 2,873 $15.07 $43,296.11
Disclosure

SEC source: 0000950170-25-063652 · ownership.xml · nonDerivative · entry 1

Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,038

F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document
May 01, 2025 Filed May 5, 2025 20:53 UTC
Jain AbhishekChief Financial Officer
Tax withholdingCommon Stock 7,686 $15.07 $115,828.02
Disclosure

SEC source: 0000950170-25-063651 · ownership.xml · nonDerivative · entry 1

Jain Abhishek · CIK 0001931277 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 329,394

F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document
April 30, 2025 Filed May 2, 2025 20:49 UTC
Maag PeterDirector
SaleCommon Stock 13,281 $17.23 $228,795.77
Disclosure

SEC source: 0000950170-25-062877 · ownership.xml · nonDerivative · entry 1

Maag Peter · CIK 0001613855 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 316,743

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 21, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.8500 to $17.6900, inclusive. The reporting person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
April 21, 2025 Filed Apr 23, 2025 20:20 UTC
Jain AbhishekChief Financial Officer
Tax withholdingCommon Stock 338 $16.94 $5,725.72
Disclosure

SEC source: 0001931277-25-000010 · wk-form4_1745439615.xml · nonDerivative · entry 1

Jain Abhishek · CIK 0001931277 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 337,080

F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document
April 15, 2025 Filed Apr 17, 2025 20:35 UTC
Hanna John Walter JRDirector · President & CEO
Tax withholdingCommon Stock 61,469 $19.16 $1,177,746.04
Disclosure

SEC source: 0001781127-25-000004 · wk-form4_1744922094.xml · nonDerivative · entry 1

Hanna John Walter JR · CIK 0001781127 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 627,041

F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document
April 07, 2025 Filed Apr 9, 2025 20:30 UTC
Novack Jeffrey AdamSecretary and General Counsel
SaleCommon Stock 924 $17.72 $16,373.28
Disclosure

SEC source: 0002019976-25-000006 · wk-form4_1744230605.xml · nonDerivative · entry 1

Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,911

F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document
April 07, 2025 Filed Apr 9, 2025 20:31 UTC
Jain AbhishekChief Financial Officer
SaleCommon Stock 265 $17.72 $4,695.80
Disclosure

SEC source: 0001931277-25-000008 · wk-form4_1744230677.xml · nonDerivative · entry 1

Jain Abhishek · CIK 0001931277 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 337,418

F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 20:31 UTC GrantCommon Stock 967 $0.00 $0.00
Disclosure

SEC source: 0001366412-25-000005 · wk-form4_1744144267.xml · nonDerivative · entry 1

Goldberg Michael · CIK 0001366412 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,895

F1 · shares: Represents an automatic quarterly grant of common stock to the Reporting Person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
March 21, 2025 Filed Mar 25, 2025 20:31 UTC
Novack Jeffrey AdamSecretary and General Counsel
GrantCommon Stock 23,158 $0.00 $0.00
Disclosure

SEC source: 0002019976-25-000004 · wk-form4_1742934704.xml · nonDerivative · entry 1

Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,835

F1 · shares: The reported securities are represented by restricted stock units, of which one-third will vest on April 1, 2026 and the remaining two-thirds will vest in equal quarterly installments thereafter on the last day of each of the subsequent eight quarters, rounded down to the nearest whole share until the last such installment, such that one-hundred percent of the restricted stock units will be vested on the third anniversary of April 1, 2026, subject to the Reporting Person's continuous employment on each applicable vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.